BCMA+ EV levels correlate with myeloma response to belantamab-mafodotin
A new research paper was published in Oncotarget, entitled, "Plasma levels of BCMA-positive extracellular vesicles correlate to response and side effects in myeloma patients treated with belantamab-mafodotin."
Dec 7, 2023
0
1